The introduction of a biological control agent (BCA) that is a new organism is regulated by the Environmental Risk Management Authority (ERMA) New Zealand under the Hazardous Substances and New Organisms (HSNO) Act 1996. The purpose of this poster is to provide guidance for researchers on, and an opportunity to discuss, the preparation of comprehensive release applications. The level of detail required and quality of a comprehensive application is similar to that found in a funding proposal or scientifi c paper. Clear evidence on the risks, costs and benefi ts substantiated with sound scientifi c data and logical arguments about the level of uncertainty should be presented. To gain approval applicants need to demonstrate that any risks or costs associated with the release of a BCA are outweighed by the benefi ts. The potential adverse effects associated with the release of a BCA generally arise from impacts on non-target organisms. It is vital that applicants explain the rationale and outcome of the host-specifi city testing. Proof of benefi ts often hinges on demonstrating the ability of the BCA to establish and to be effective against the chosen host. Sources of information to help with the preparation of applications will be provided.
